Back

Clinical significance of B-type natriuretic peptide levels at 3-month after atrial fibrillation ablation

27 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Atrial fibrillation - Ablation Rhythm Control, Catheter Ablation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Sen Matsumoto

JCHO Hoshigaoka Medical Center, Hirakata (Japan)

11 More presentations in this session

Presentation thumbnail
Mr M. Mulder (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Doctor K. Murata (Saitama, JP)
Abstract Slides
Presentation thumbnail
Professor D. Scherr (Graz, AT)
Abstract Slides
Presentation thumbnail
Doctor M. Janotka (Prague, CZ)
Abstract
Presentation thumbnail
Mr M. Nagano (Kobe, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Atrial fibrillation - Ablation

The Event

Event poster

ESC Congress 2018

27 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of the diagnostic significance of various types of natriuretic peptides in patients with heart failure on the background of atrial fibrillation and chronic obstructive pulmonary disease
29 June 2021
thumbnail
Congress Presentation
Reverse structural and functional left atrial remodeling after successful catheter ablation for paroxysmal atrial fibrillation.
13 December 2024
thumbnail
Congress Presentation
Secretoneurin plasma levels are decreased after catheter ablation for atrial fibrillation, patients with AF produce lower SN levels than healthy individuals
1 September 2024
thumbnail
Congress Presentation
Predictive value of biomarker dynamics for atrial fibrillation recurrence after pulmonary vein isolation: a prospective cohort study
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources